Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Scientific Reports
|
February 17, 2026
Non-invasive stroke volume assessment during cardiopulmonary exercise testing provides additional insight beyond O<sub>2</sub>-pulse in hypertrophic cardiomyopathy
Massimo Mapelli, Nikita Baracchini, Nicola Campana, et al.
Respiratory Research
|
February 8, 2024
Symptomatic post COVID patients have impaired alveolar capillary membrane function and high VE/VCO<sub>2</sub>
Piergiuseppe Agostoni, Massimo Mapelli, Elisabetta Salvioni, et al.
International Journal of Molecular Sciences
|
August 28, 2025
Short-term effects of DAPAgliflozin on Lung fUNction, sleep apneas, and circulatinG surfactant protein B in Heart Failure with reduced ejection fraction (DAPA-LUNG-HF)
Massimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, et al.
Frontiers in Cardiovascular Medicine
|
April 1, 2025
Dapagliflozin effects on exercise, cardiac remodeling, biomarkers, and renal and pulmonary function in heart failure patients: not as good as expected?
Massimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, et al.
European Journal of Preventive Cardiology
|
August 12, 2025
Cardiopulmonary exercise testing in hypertrophic cardiomyopathy: the role of reduced O2 pulse and chronotropic incompetence in myocardial adaptation
Robin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Journal of the American Heart Association
|
April 9, 2026
RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy
Robin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Open Heart
|
June 30, 2026
Beyond the slope: prognostic utility of the VE/VCO<sub>2</sub> intercept in chronic heart failure
Piergiuseppe Agostoni, Robin Willixhofer, Arianna Galotta, et al.
Journal of Clinical Medicine
|
January 11, 2024
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban
Massimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, et al.
European Journal of Heart Failure
|
November 30, 2019
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction
Sara Rovai, Ugo Corrà, Massimo Piepoli, et al.
European Journal of Heart Failure
|
September 13, 2023
Heart failure patients with improved ejection fraction: Insights from the MECKI score database
Piergiuseppe Agostoni, Francesca Romana Pluchinotta, Elisabetta Salvioni, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Scientific Reports
|
February 17, 2026
Non-invasive stroke volume assessment during cardiopulmonary exercise testing provides additional insight beyond O<sub>2</sub>-pulse in hypertrophic cardiomyopathy
Massimo Mapelli, Nikita Baracchini, Nicola Campana, et al.
Respiratory Research
|
February 8, 2024
Symptomatic post COVID patients have impaired alveolar capillary membrane function and high VE/VCO<sub>2</sub>
Piergiuseppe Agostoni, Massimo Mapelli, Elisabetta Salvioni, et al.
International Journal of Molecular Sciences
|
August 28, 2025
Short-term effects of DAPAgliflozin on Lung fUNction, sleep apneas, and circulatinG surfactant protein B in Heart Failure with reduced ejection fraction (DAPA-LUNG-HF)
Massimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, et al.
Frontiers in Cardiovascular Medicine
|
April 1, 2025
Dapagliflozin effects on exercise, cardiac remodeling, biomarkers, and renal and pulmonary function in heart failure patients: not as good as expected?
Massimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, et al.
European Journal of Preventive Cardiology
|
August 12, 2025
Cardiopulmonary exercise testing in hypertrophic cardiomyopathy: the role of reduced O2 pulse and chronotropic incompetence in myocardial adaptation
Robin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Journal of the American Heart Association
|
April 9, 2026
RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy
Robin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Open Heart
|
June 30, 2026
Beyond the slope: prognostic utility of the VE/VCO<sub>2</sub> intercept in chronic heart failure
Piergiuseppe Agostoni, Robin Willixhofer, Arianna Galotta, et al.
Journal of Clinical Medicine
|
January 11, 2024
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban
Massimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, et al.
European Journal of Heart Failure
|
November 30, 2019
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction
Sara Rovai, Ugo Corrà, Massimo Piepoli, et al.
European Journal of Heart Failure
|
September 13, 2023
Heart failure patients with improved ejection fraction: Insights from the MECKI score database
Piergiuseppe Agostoni, Francesca Romana Pluchinotta, Elisabetta Salvioni, et al.
Page
of 6